コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gulated proliferative response by activating Src family kinase.
2 yrosine phosphorylation is controlled by the Src family kinase.
3 ed production of ROS that was independent of Src family kinases.
4 le phosphorylation and activation of PI3K by Src family kinases.
5 ng the C-terminal inhibitory tyrosine of the src family kinases.
6 and provide insights into transformation by Src family kinases.
7 ells phosphorylates SLP-76 in the absence of SRC family kinases.
8 yrosine phosphorylation on FcRgamma chain or Src family kinases.
9 osphorylating the inhibitory tyrosine of the Src family kinases.
10 inding region of M2 and its interaction with Src family kinases.
11 osphorylating the inhibitory tyrosine of the src family kinases.
12 d cortactin were identified as substrates of Src family kinases.
13 s suggest a role of GD3 in the regulation of Src family kinases.
14 could be attributed to reduced activation of Src family kinases.
15 its NPXY domains through phosphorylation by Src family kinases.
16 g Abl localization and Abl/Arg activation by Src family kinases.
17 ested that this occurs through inhibition of Src family kinases.
18 c-Src is a tyrosine kinase belonging to the Src-family kinases.
19 r for C-terminal SRC kinase, an inhibitor of SRC-family kinases.
20 host cell effectors, including Hck and other Src-family kinases.
21 inding affinities of Gleevec between the two Src-family kinases.
22 s activity does not appear to be mediated by Src-family kinases.
23 ation, and Integrin beta1 phosphorylation by Src-family kinases.
24 gage cytoplasmic signaling molecules such as Src-family kinases.
25 tinib, a clinical Bcr-Abl inhibitor, targets Src-family kinases.
26 omain regulatory interaction exists in other Src-family kinases.
31 cal reagents, PP2 and Dasatinib, which block Src family kinase activation, blocked scattered growth o
32 that often overexpress SOCS1 also displayed SRC family kinase activation, constitutive phosphorylati
33 cription and secretion through inhibition of Src family kinase activation, particularly Lck, downstre
36 of this inhibitory circuit was dependent on Src-family kinase activity and consequent to biased BCR
38 nd treatment with dasatinib, an inhibitor of Src family kinases, also mimics the effects of versican.
40 induces CaM phosphorylation at Tyr(99) by a Src family kinase and that phosphorylated CaM activates
42 myristic acid analog known to interact with Src family kinases and an inhibitor of cyclin dependent
44 lusive interaction between SRC but not other Src family kinases and FLT3-ITD, which is mediated by th
45 sites depends on the direct interaction with Src family kinases and is upstream of the activation by
46 e co- or posttranslational myristoylation of Src family kinases and other oncogenic proteins, thereby
48 resulted in the following: 1) activation of Src family kinases and Syk revealed by their recruitment
51 analysis showed that SHP2 activates several SRC-family kinases and downstream targets, most of which
52 ion of integrins and involves stimulation of Src-family kinases and focal adhesion kinase, as well as
53 The synthesis of ROS by oxLDL/CD36 required Src-family kinases and protein kinase C (PKC)-dependent
55 ultimerization of DCC, activation of FAK and Src family kinases, and increases in exocytic vesicle fu
56 required for TGFbeta1-mediated activation of Src family kinases, and Src inhibition blocked both pY65
57 at the tyrosine residue is phosphorylated by Src family kinases, and that Src-activation limits surfa
60 d DC activation occurred within minutes in a Src-family-kinase- and CD18-integrin-dependent manner.
61 e function of Csk as a negative regulator of Src family kinases appears to have arisen with the emerg
66 cence pathway and suggest that inhibition of SRC family kinases as personalized treatment in patients
68 Delta;Y567F/Y567F) knock-in mice lacking the SRC family kinase-binding site on KIT (pY567) exhibited
70 e not accompanied by the expected decline of Src family kinases but were accompanied by Akt-mammalian
72 signals through an evolutionarily conserved Src family kinase cascade to drive cytoskeletal rearrang
73 of Eps8 aimed to identify specific FGFR and Src family kinase dependent phosphosites and co-associat
75 endogenous ROS activate TrkB signaling by a Src family kinase-dependent but brain-derived neurotroph
76 estricts TGF-beta1 secretion in a Cdc42- and Src family kinase-dependent manner and independently of
79 Thus, extracellular actin detection via a Src-family kinase-dependent cascade is an ancient means
80 nduced CLEC-2 immunodepletion occurs through Src-family kinase-dependent receptor internalization in
81 ylation of a neighboring tyrosine residue by Src family kinases disrupts COP1 binding, thereby stabil
83 2)R-cGMP downstream signaling molecules Src (Src family kinase), ERK (extracellular signal-related ki
85 tion increased receptor association with the Src family kinase Fgr and shifted signals from the adapt
87 the specific requirement of HCK p59 and FGR src-family kinases for FCRL4-mediated immunomodulatory a
90 he slit diaphragm and transduce signals in a Src family kinase Fyn-mediated tyrosine phosphorylation-
97 cells, and these genes include seven of nine Src family kinase genes, FGFR1, FGFR2, ITK, NTRK1, NTRK2
98 splaying high potency and selectivity toward SRC family kinases have been developed by combining liga
99 r 3 uses templated catalysis to redirect the Src family kinase Hck to phosphorylate hDM2, a negative
106 cellent selectivity over other TEC, EGFR and Src family kinases, (ii) desirable ADME, excellent in vi
108 THrP elevated Y418 phosphorylation levels in Src family kinases in CD11b(+)Gr1(+) cells via osteoblas
110 Interestingly, it also positively regulates Src family kinases in hematopoietic and endothelial cell
112 ving cells, providing evidence for a role of Src family kinases in regulating growth factor induced A
113 morphology changes, which are independent of SRC family kinases in Src-/-, Yes-/-, Fyn-/- (SYF) mouse
115 osignaling and control of RhoA and implicate Src family kinases in the regulation of p115 RhoGEF.
117 his study, we investigate the roles of these src-family kinases in FCRL4-mediated immunoregulation of
120 thermore, MCR-independent phosphorylation of Src family kinase induces IgF1 receptor phosphorylation,
123 rylation is compromised in the presence of a Src family kinase inhibitor and when the SH3 domains of
127 regulated kinase (ERK1/2) was blocked by the Src family kinase inhibitor PP2, indicating that the act
128 , and cerebrospinal fluid penetration of the Src family kinase inhibitor saracatinib in patients with
129 nical trials using single agent dasatinib, a SRC family kinase inhibitor, have failed in sarcomas.
130 leles exhibited a greater sensitivity to the Src family kinases inhibitor dasatinib in response to co
131 sed the effect of TNF-alpha, with or without src-family kinase inhibitor SU6656, on barrier propertie
133 t; 0.25 or 2.5 mug/0.5 mul/hemisphere), PP2 (Src-family kinase inhibitor; 6.25 or 62.5 ng/0.5 mul/hem
137 he PSGL-1-L-selectin complex signals through Src family kinases, ITAM domain-containing adaptor prote
139 rotein HER-2 increased the activation of the Src family kinase LCK and cytokine-induced STAT-5 signal
140 ng to regulate T cell lineage commitment and SRC family kinase LCK and STAT5 signaling to regulate al
143 respond to antigen because it activates the Src family kinase Lck, which phosphorylates the T cell a
147 ncreased activity of the negative regulatory Src family kinase Lyn and reduced activities of the posi
148 cancer cells feature high expression of the Src family kinase Lyn that has been implicated in the pa
150 e tyrosine-phosphorylated by Pyk2, bound the Src-family kinase Lyn and linked TLR9 to a Src-kinase Sy
151 presence of epidermal growth factor (EGF) by Src family kinase-mediated phosphorylation on c-Abl-Tyr4
153 se activation, NMDAR stimulation, and likely Src-family kinase-mediated NR2B subunit-containing NMDAR
154 hermore, the trophic factor S100beta induces Src-family kinase-mediated tyrosine phosphorylation of h
156 e with ActApo, including p38, JNK, PI3K-Akt, Src family kinases, NFkappaB p65, and AP1 transcription
158 tein that can function by the recruitment of Src family kinases or by competition with phosphatases.
159 nd is therefore capable of signaling without SRC family kinases or stimulation of the T cell receptor
161 onocytes and that inhibition of the MAPK and Src family kinase pathways blocked the ability of CD4 li
162 In addition to abrogating myristoylation of Src family kinases, PCLX-001 also promotes their degrada
163 he signaling through spleen tyrosine kinase, Src family kinases, phosphatidylinositol-3-kinase, and p
164 urs via a novel, sequential process in which Src family kinases phosphorylate the C-terminal ITIM, th
166 C-2 receptor clustering, followed by Syk and Src family kinase phosphorylation, determined by the clu
171 lly, phospho-specific staining for Zap70 and Src family kinase proteins suggests that sensing of subs
172 er, the identification of YY1 as a target of Src family kinases provide key insights into the inhibit
173 The corolla amplified active phosphorylated Src-family kinases (pSFK), LAT and PLC-gamma over T cell
174 ptor type-protein tyrosine phosphatase alpha-Src family kinase-Rap1 pathway as responsible for recrui
177 encodes a tyrosine phosphatase that inhibits Src-family kinases responsible for Ag receptor signaling
179 Nef binds to the Src homology 3 domains of Src family kinases, resulting in kinase activation impor
180 either the SH3 or tandem SH3-SH2 domains of Src-family kinases reveal distinct dimer conformations o
182 Finally, we demonstrated that JAM-C controls Src family kinase (SFK) activation in LSC and that LIC w
184 Moreover, we present in vivo evidence that Src family kinase (SFK) activity is critical for PCP reg
185 the autophosphorylation site tyrosine in the SRC family kinase (SFK) FYN as well as Tyr142 in beta-ca
186 ro model of dormancy to evaluate the role of Src family kinase (SFK) in regulating this dormant-to-pr
187 of intracellular calcium but is sensitive to SRC family kinase (SFK) inhibition, suggestive of channe
189 s study, we show that the pyrrolo-pyrimidine Src family kinase (SFK) inhibitor PP2 effectively promot
190 tivation was completely abolished by the pan-Src family kinase (SFK) inhibitor, PP2, or when Syk is i
191 was inhibited in the presence of PP2, a pan-src family kinase (SFK) inhibitor, suggesting that c-Cbl
194 uced H2O2 is detected by the redox-sensitive Src family kinase (SFK) Lyn within the responding blood
197 We tested the hypothesis that regulation of SRC family kinase (SFK) signaling by the scaffold protei
199 alternative signaling activation mechanisms, Src family kinase (SFK) signaling is sufficient to trans
201 ined that CRKL signaling was associated with SRC family kinase (SFK) signaling, specifically with YES
202 nding macrophages by directly activating the Src family kinase (SFK) Src42A,(3) which in turn phospho
203 resulted in increased phosphorylation of the SRC family kinase (SFK) YES, increased expression of WNT
204 identified the concomitant activation of an Src family kinase (SFK), hematopoietic cell kinase (HCK)
207 glioblastoma, promotes tumorigenesis through Src family kinase (SFK)-dependent phosphorylation of Doc
208 educed GPVI expression and signaling via the Src family kinase (SFK)-Syk-PLCgamma2 pathway, and fibri
209 ne lipid rafts, leading to the activation of Src Family Kinase (SFK)/hemopoietic cell kinase (Hck) an
212 tion of type-1 TNF receptors, recruitment of Src family kinases (SFK) and SFK-dependent phosphorylati
213 ustion through TICAM2 mediated activation of Src family kinases (SFK) and STAT1, as the application o
215 n of these differences is that inhibition of Src family kinases (SFK) blocks TCR but not BCR signalin
218 ORF4 protein (E4orf4) subverts signaling by Src family kinases (SFK) to perturb cellular morphology,
220 been shown to confer enhanced sensitivity to SRC-family kinase (SFK) inhibitors in other malignancies
223 ation through receptor tyrosine kinase (RTK)/SRC-family kinase (SFK) signaling or mutant NRAS, which
224 ase (Csk), the primary negative regulator of Src-family kinases (SFK), plays a crucial role in contro
226 d by PDGF, reactive oxygen species (ROS) and Src family kinases (SFKs) act downstream of PDGFRs to en
228 hese receptors lacking the binding sites for Src family kinases (SFKs) and phosphatidylinositol-3-kin
230 engagement of LFA-1 led to the activation of SRC family kinases (SFKs) and SFK inhibition blocked cyt
231 e, we report that RUNX1 is phosphorylated by Src family kinases (SFKs) and that this occurs on multip
235 both fibroblast growth factor receptors and SRC family kinases (SFKs) but does not affect the abilit
237 ally, we found that different members of the Src family kinases (SFKs) can promote RIP2 tyrosine phos
238 oblastoma (GBM), the EGF receptor (EGFR) and Src family kinases (SFKs) contribute to an aggressive ph
239 Here we investigate how flaviviruses exploit Src family kinases (SFKs) for exit from infected cells.
244 tyrosine phosphorylation indicated that, the Src family kinases (SFKs) were found to phosphorylate CD
248 d this, we identified the involvement of the Src family kinases (SFKs), based upon the ability of SFK
249 ion of the C-terminal inhibitory tyrosine of SRC family kinases (SFKs), implicating CD148 as a critic
250 induced by IGF-1 can occur in cells lacking Src family kinases (SFKs), indicating that an unknown ki
251 embrane protein that acts as a substrate for SRC family kinases (SFKs), is overexpressed in a subset
252 r of the group of tyrosine kinases named the Src family kinases (SFKs), is overexpressed, associated
253 , and subsequent TSAd-mediated activation of Src family kinases (SFKs), SFKs engage the receptor tyro
254 telet activation signals in conjunction with Src family kinases (SFKs), spleen tyrosine kinase (Syk),
256 ER stress coincided with the inhibition of Src family kinases (SFKs), which was exacerbated by PTP1
262 SRC (proto-oncogene tyrosine-protein kinase Src) family kinases (SFKs), can be found in a significan
264 le of phosphoinositide 3-kinases (PI3Ks) and Src-family kinases (SFKs) in these responses using human
266 haride-induced cell migration, activation of Src-family kinases (SFKs), and phosphorylation of focal
272 ique and often contradictory roles played by Src-family-kinases (SFKs) in regulating cell physiology,
273 ng the underlying actin cytoskeleton through Src family kinase signaling and m-Tor-dependent protein
274 cones responses involve the potentiation of Src family kinase signaling, a common effector of both p
275 moattraction, or by pharmacological block of Src family kinase signaling, consistent with receptor re
276 quitination of Ag.BCR complexes occurs by an Src family kinase signaling-dependent mechanism that is
280 3BP2 is required for optimal activation of Src family kinases, small GTPase Rac2, neutrophil supero
282 e carcinoma is associated with activation of SRC family kinase (SRC, YES, FYN) activity and loss of c
283 factor-beta (TGF-beta), RhoA/Rho-kinase and Src-family kinases (SrcFK) have independently been impli
285 hosphorylation of the SH2-kinase linker by a SRC family kinase such as LYN proto-oncogene, SRC family
286 leading to integrin activation via the SFK (Src family kinase)-Syk (spleen tyrosine kinase)-PLCgamma
287 ithin RECs by elevating ROS, which activated Src-family kinases that stimulated the extracellular sig
288 -alphavbeta3 coupling altered recruitment of Src family kinases to adhesion complexes and impaired me
290 Moreover, the activatory phosphorylation of Src family kinases was considerably delayed as well as t
291 orylation of Syk, Akt, and ERK, but not SFK (Src family kinase), was significantly reduced in RhoG-de
292 fic contribution of c-Src, one member of the Src family kinases, was demonstrated using c-Src-deficie
293 Rac1/WAVE2 and Cdc42/WASP pathways, whereas Src family kinases were required for proper WASP tyrosin
295 gnificant homology with other members of the Src family kinases, which may lead to unintended off-tar
297 ivating components in the network, including Src family kinases, whose inhibition affects only a subs
298 trated by independent association of the Lyn Src-family kinase with an intracellular immunoreceptor t
299 We have previously demonstrated that the Src family kinase Yes, the Yes-associated protein (YAP)
300 c studies showed that these TKIs inhibit the Src family kinase Yes1, which was found to be essential